Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
In addition to IV therapy, eating bland foods such as dry cereal, saltine crackers, oatmeal, and potatoes can help ease symptoms and support recovery
Long-term human safety has not been established, and telomerase activity is relevant to malignant-cell survival
India Asian J Adv Basic Sci 7(2):4249 Kumar G, Rana S (2016) Eco-ethnological and aromatic plants of Jahu valley region Himachal Pradesh, India
Kvietkauskas M, et al
We can talk by email, skype, whatsapp, phone or whatever you feel convenient
